← All stocks

ACM Research, Inc.

ACMR Scheduled selling only

CIK 0001680062 #1301 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$53.05M

$0.00 on a plan · $53.05M straight out of an exercise

Sold at will

$0.00

0 of 75 sales

Net

−$53.05M

$0.00 against sales at will

By person

12 insiders · 75 transactions

493×

David H. Wang holds 493 times base salary in stock. $132.11M of shares against $267.80K in salary for 2025.

Salary from the company's own proxy. The shares are what David H. Wang last reported holding, valued at $77.59, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Wang David H

See Remarks

—

$28.98M (29) scheduled

−$28.98M

1,702,711

2.5%

$132.11M

+21.3%

McKechnie Mark

See Remarks

—

$9.85M (12) scheduled

−$9.85M

900

0.001%

$69.83K

0.0%

Chen Fuping

See remarks

—

$3.98M (3) scheduled

−$3.98M

0.000%

$0.00

—

Liu Tracy

Director

—

$3.35M (5) scheduled

−$3.35M

110,772

0.163%

$8.59M

0.0%

Feng Lisa

See remarks

—

$2.44M (6) scheduled

−$2.44M

50,001

0.074%

$3.88M

0.0%

Cheav Sotheara

See remarks

—

$1.94M (8) scheduled

−$1.94M

100,002

0.147%

$7.76M

0.0%

Wang Jian

See remarks

—

$1.05M (1) scheduled

−$1.05M

253,158

0.373%

$19.64M

0.0%

Dun Haiping

Director

—

$954.14K (9) scheduled

−$954.14K

0.000%

$0.00

−100.0%

Pappis Charles C

Director

—

$510.45K (2) scheduled

−$510.45K

0.000%

$0.00

—

Shanghai Science & Technology Venture Capital (Group) Co., Ltd. entity

10% owner

—

2,338,510

3.4%

$181.44M

−32.0%

Xing Xiao

Director

—

2,338,510

3.4%

$181.44M

−32.0%

Hu Chenming

Director

—

100,002

0.147%

$7.76M

−62.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 75

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,758,842

History held since 17 May 2018